Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Saul Shiffman
University of Pittsburgh at Pittsburgh, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
JSR, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Shiffman has entered a consultancy with Niconovum, which has a commercial interest in the nicotine replacement medication being evaluated in this research. He is also an inventor of a competing gum licensed to JSR, LLC, in which he holds equity.
Cessation in Non-Daily Smokers: A RCT of NRT with Ecological Momentary Assessment
US smoking patterns are changing as more and more adult smokers report that they don't smoke every day. Contrary to popular belief, these 'non-daily' smokers actually show signs of addiction to cigarettes, and have trouble quitting. In this study we will test whether nicotine gum is helpful for non-daily smokers who are trying to quit. The research subjects will carry smartphones that ask them about things like mood, stress, craving, withdrawal symptoms (irritability), etc., so that we can learn more about their 'real world' experience before and after quitting smoking. .
Filed on May 14, 2015.
Tell us what you know about Saul Shiffman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Saul Shiffman”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Saul Shiffman | University of Pittsburgh at Pittsburgh | Conflict of Interest | GlaxoSmithKline | $20,000 - $39,999 |
| Saul Shiffman | University of Pittsburgh at Pittsburgh | Conflict of Interest | JSR, LLC | $80,000 - $99,999 |
| Saul Shiffman | University of Pittsburgh at Pittsburgh | Conflict of Interest | JSR, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.